Versiguard Rabies, Suspension for injection
Versiguard Rabies, Suspension for injection
Authorised
- Rabies virus, strain SAD Vnukovo-32, Inactivated
Product identification
Medicine name:
Versiguard Rabies, Suspension for injection
Vanguard R Suspensie voor injectie
Vanguard R Suspension injectable
Vanguard R Injektionssuspension
Active substance:
- Rabies virus, strain SAD Vnukovo-32, Inactivated
Target species:
-
Cat
-
Cattle
-
Pig
-
Sheep
-
Goat
-
Horse
-
Ferret
-
Dog
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain SAD Vnukovo-32, Inactivated2.00international unit(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cat
- Cattle
-
Milk0hour
-
Meat and offal0day
-
- Pig
-
Meat and offal0day
-
- Sheep
-
Milk0hour
-
Meat and offal0day
-
- Goat
-
Milk0hour
-
Meat and offal0day
-
- Horse
-
Milk0hour
-
Meat and offal0day
-
- Ferret
-
Subcutaneous use
- Dog
- Cat
- Cattle
-
Milk0hour
-
Meat and offal0day
-
- Pig
-
Meat and offal0day
-
- Sheep
-
Milk0hour
-
Meat and offal0day
-
- Goat
-
Milk0hour
-
Meat and offal0day
-
- Horse
-
Milk0hour
-
Meat and offal0day
-
- Ferret
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Glass Vial 1 x 1.0 Dose
- Glass Vial 10 x 10.0 Dose
- Glass Vial 10 x 1.0 Dose
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V284995
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0100/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: